{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:24:45Z","timestamp":1767147885195,"version":"build-2238731810"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nrl.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T01:09:49Z","timestamp":1591578589000},"page":"357-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tratamiento inmunosupresor en pulsos en esclerosis m\u00faltiple durante el desescalado de la epidemia por SARS-CoV-2. Algoritmo de seguridad"],"prefix":"10.1016","volume":"35","author":[{"given":"G.","family":"Valero-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carre\u00f3n-Guarnizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hern\u00e1ndez-Clares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Iniesta-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moreno-Docon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Iborra-Bendicho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Aznar-Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Hell\u00edn-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morales-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Meca-Lallana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2020.06.001_bib0115","unstructured":"Centro de coordinaci\u00f3n de alertas y emergencias sanitarias. Informaci\u00f3n cient\u00edfico-t\u00e9cnica. Enfermedad por coronavirus COVID-19. Aportaciones: Inmunodepresi\u00f3n. Ministerio de Sanidad. [consultado 17 Abr 2020] Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/20200417_ITCoronavirus.pdf"},{"key":"10.1016\/j.nrl.2020.06.001_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic","author":"D\u0301Antiga","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.nrl.2020.06.001_bib0125","doi-asserted-by":"crossref","first-page":"102073","DOI":"10.1016\/j.msard.2020.102073","article-title":"The COVID-19 pandemic and the use of MS disease-modifying therapies","volume":"39","author":"Giovannoni","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.nrl.2020.06.001_bib0130","first-page":"329","article-title":"Garc\u00eda-Dom\u00ednguez Documento EMCAM (Esclerosis M\u00faltiple Comunidad Aut\u00f3noma de Madrid) para el manejo de pacientes con esclerosis m\u00faltiple durante la pandemia de SARS-CoV-2","volume":"70","author":"Costa-Frossard","year":"2020","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2020.06.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009507","article-title":"Treating Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic","author":"Brownlee","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.06.001_bib0140","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2014-307591","article-title":"Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis","volume":"85","author":"Gueguen","year":"2014","journal-title":"J NeurolNeurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2020.06.001_bib0145","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00415-014-7325-8","article-title":"Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients","volume":"261","author":"Sorensen","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2020.06.001_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40120-019-00160-9","article-title":"Fingolimod\u00a0Rebound: A Review of the Clinical Experience and Management Considerations","volume":"8","author":"Barry","year":"2019","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nrl.2020.06.001_bib0155","unstructured":"Recomendaciones de tratamiento oncol\u00f3gico en pacientes con tumores testiculares en momentos de epidemia por COVID19. Presidente del Grupo Germinal, en nombre de los miembros de la Junta Directiva del Grupo Germinal. Valencia, 1 Abr 2020."},{"key":"10.1016\/j.nrl.2020.06.001_bib0160","unstructured":"Grupo de investigaci\u00f3n espa\u00f1ol en c\u00e1ncer de mama (GEICAM). Documento GEICAM sobre el manejo del paciente con c\u00e1ncer de mama en la situaci\u00f3n de pandemia de COVID-19 en Espa\u00f1a. [consultado 2 Abr 2020] Disponible en: https:\/\/seom.org\/images\/GEICAM_Recomendaciones_COVID_19_Cancer_de_Mama.pdf"},{"key":"10.1016\/j.nrl.2020.06.001_bib0165","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"NEJM"},{"key":"10.1016\/j.nrl.2020.06.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2001801","article-title":"Covid-19 in South Korea - Challenges of\u00a0Subclinical\u00a0Manifestations","author":"Song","year":"2020","journal-title":"NEJM"},{"key":"10.1016\/j.nrl.2020.06.001_bib0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/d41586-020-00166-6","article-title":"China coronavirus: Six questions scientists are asking","volume":"577","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nrl.2020.06.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nrl.2020.06.001_bib0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2020.06.001_bib0190","unstructured":"EMA. Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic. Version 1.(20\/03\/2020)."},{"key":"10.1016\/j.nrl.2020.06.001_bib0195","unstructured":"Propuesta de medidas y cuestiones a considerar para la fase de transici\u00f3n de la pandemia por SARS-CoV-2 en Espa\u00f1a. Informe t\u00e9cnico de la Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica e Higiene (SEMPSPH). [consultado 10 Abr 2020] Disponible en: https:\/\/www.sempsph.com\/images\/Informe%20SEMPSPH.%20Propuesta%20de%20medidas%20y%20aspectos%20a%20considerar%20en%20la%20fase%20de%20transici\u00f3n.pdf"},{"key":"10.1016\/j.nrl.2020.06.001_bib0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10072-020-04391-9","article-title":"Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic","volume":"41","author":"Bonavita","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2020.06.001_bib0205","unstructured":"Interpretaci\u00f3n de las pruebas diagn\u00f3sticas frente a SARS-CoV-2. Instituto de Salud Carlos III. Colaboraci\u00f3n de la Sociedad Espa\u00f1ola de enfermedades infecciosas y microbiolog\u00eda cl\u00ednica. Ministerio de Sanidad. [consultado 22 Abr 2020] Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/INTERPRETACION_DE_LAS_PRUEBAS.pdf"},{"key":"10.1016\/j.nrl.2020.06.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nrl.2020.06.001_bib0215","unstructured":"Gu\u00eda para la utilizaci\u00f3n de test r\u00e1pidos de anticuerpos para COVID-19. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. Ministerio de Sanidad. [consultado 7 Abr 2020] Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/Guia_test_diagnosticos_serologicos_20200407.pdf"},{"key":"10.1016\/j.nrl.2020.06.001_bib0220","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years","volume":"68","author":"Kim","year":"2011","journal-title":"Arch Neurol"}],"updated-by":[{"DOI":"10.1016\/j.nrl.2020.07.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000}}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320301389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320301389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T13:46:58Z","timestamp":1595252818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485320301389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0213485320301389"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2020.06.001","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento inmunosupresor en pulsos en esclerosis m\u00faltiple durante el desescalado de la epidemia por SARS-CoV-2. Algoritmo de seguridad","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}